The identification of SCARB2 as a receptor for EV71 provides a molecular basis for understanding the viral entry mechanism and pathogenesis of hand-foot-mouth disease and its severe neurological complications.
Answers are grounded in this paper and cite their sources.
Preclinical receptor identification in animal models; leaves open whether SCARB2 blockade alters human EV71/CVA16 disease.
Enterovirus 71 (EV71) and coxsackievirus A16 (CVA16), belonging to family Picornaviridae, genus Enterovirus, species A, are causative agents of hand-foot-mouth disease (HFMD). Infections involving EV71, but not CVA16, can progress to severe neurological disease, including aseptic meningitis, encephalitis, acute flaccid paralysis and neurogenic pulmonary edema. EV71 is thus considered to be a neuropathogenic virus and EV71 outbreak has become a major public health concern. Human RD cells are highly susceptible to EV71, while mouse L929 cell are not. We established mouse cell lines that acquired EV71-susceptibility by transfecting human genomic DNA. We succeeded in identifying a human gene, scavenger receptor B2 (SCARB2), integrated in one of the transformant cells by microarray analysis and showed that SCARB2 can serve as a EV71 receptor. I will summarize this result, background and the methodology of the study.
No takes yet. Share an insight, caveat, or question.
Satoshi Koike (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: